valsartan has been researched along with Cicatrix, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akoz Saydam, F; Bozkurt, M; Caglar, A; Kurt, M; Serin, M | 1 |
| Chen, X; Chen, ZG; Cheng, B; Gu, YF; Liu, HW; Liu, WZ; Wu, HJ | 1 |
2 other study(ies) available for valsartan and Cicatrix, Hypertrophic
| Article | Year |
|---|---|
The effects of valsartan on scar maturation in an experimental rabbit ear wound model.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cicatrix, Hypertrophic; Collagen; Ear; Enalapril; Fibroblasts; Male; Models, Animal; Rabbits; Valsartan; Wound Healing | 2020 |
[The effect of angiotensin II on phosphoinositide-3 kinase/Akt cascade in cultured fibroblasts derived from patients with hypertrophic scars].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Cells, Cultured; Cicatrix, Hypertrophic; Fibroblasts; Humans; Imidazoles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles; Valine; Valsartan | 2010 |